110 related articles for article (PubMed ID: 16020972)
21. P-glycoprotein expression in non-Hodgkin's lymphomas of human immunodeficiency virus infected patients.
Tanaka PY; Calore EE
Pathol Res Pract; 2007; 203(1):1-7. PubMed ID: 17157997
[TBL] [Abstract][Full Text] [Related]
22. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
[TBL] [Abstract][Full Text] [Related]
23. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
Yu SP; Xiong YY; Tian SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
[TBL] [Abstract][Full Text] [Related]
24. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
[TBL] [Abstract][Full Text] [Related]
26. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
27. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults.
Komdeur R; Klunder J; van der Graaf WT; van den Berg E; de Bont ES; Hoekstra HJ; Molenaar WM
Cancer; 2003 Apr; 97(8):1999-2005. PubMed ID: 12673730
[TBL] [Abstract][Full Text] [Related]
29. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
[TBL] [Abstract][Full Text] [Related]
30. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
[TBL] [Abstract][Full Text] [Related]
31. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
[TBL] [Abstract][Full Text] [Related]
32. [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].
Peng ZM; Luo J; Wang WB; Wang XH; Chen JH; Lan SM
Ai Zheng; 2004 Aug; 23(8):963-7. PubMed ID: 15301725
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.
Muris JJ; Meijer CJ; Cillessen SA; Vos W; Kummer JA; Bladergroen BA; Bogman MJ; MacKenzie MA; Jiwa NM; Siegenbeek van Heukelom LH; Ossenkoppele GJ; Oudejans JJ
Leukemia; 2004 Mar; 18(3):589-96. PubMed ID: 14712286
[TBL] [Abstract][Full Text] [Related]
34. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
[TBL] [Abstract][Full Text] [Related]
35. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia.
El-Sharnouby JA; Abou El-Enein AM; El Ghannam DM; El-Shanshory MR; Hagag AA; Yahia S; Elashry R
J Oncol Pharm Pract; 2010 Sep; 16(3):179-88. PubMed ID: 19969624
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
[TBL] [Abstract][Full Text] [Related]
37. [Expressions of LRP, GST-pi and MRP1 in acute leukemia patients and its clinical significance].
Huang BT; Xiao Z; Shi YT; Ha S; Zhao WH; Gao D; Yan XH; Yang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):262-6. PubMed ID: 17493328
[TBL] [Abstract][Full Text] [Related]
38. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins.
Sánchez C; Mercado A; Contreras HR; Mendoza P; Cabezas J; Acevedo C; Huidobro C; Castellón EA
Prostate; 2011 Dec; 71(16):1810-7. PubMed ID: 21480311
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance protein expression of adult T-cell leukemia/lymphoma.
Yasunami T; Wang YH; Tsuji K; Takanashi M; Yamada Y; Motoji T
Leuk Res; 2007 Apr; 31(4):465-70. PubMed ID: 17134750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]